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Plasma Medicine
Recent demonstrations of plasma
technology in the treatment of living
cells, tissues, and organs are creating a
new field at the intersection of plasma
science and technology with biology
and medicine - Plasma Medicine. This
fascinating new field poses numerous
technological challenges and brings
to the forefront many fundamental
questionsregardingthemechanismsof
interaction between living organisms
and plasma. In order to create a
forum that brings together plasma
scientists, medical professionals, bio-
logists, and biochemists, a new con-
ference was organized: The First
International Conference on Plasma
Medicine, ICPM-1. This event tookplace
inCorpusChristi,TX, fromOctober15to
18, 2007. Themain goals of ICPMwere
to develop a common language that
experts in the various relevant fields
can all understand, to better define key
challenges and open questions, and to
move toward their effective solutions.
The technical program of ICPM-1
included 19 invited papers, 23 contri-
buted oral presentations, and 19
poster papers. The authors of these
contributions were subsequently
invited to submit their full manu-
scripts to a Special Issue of Plasma
Processes and Polymers (PPP) dedicated
to Plasma Medicine. The submitted
papers underwent the usual rigorous
refereeing process that PPP requires for
all itsmanuscript published. The result
is an excellent collection of accepted
papers found in this issue of PPP,
articles which cover many aspects of
the interaction of plasma with both
prokaryotic and eukaryotic cells.
The Guest Editors would like to
express their gratitude for the help
and support they received from the
editorial team of Plasma Processes and
Polymers, especially from Sandra Kal-
veram, who conducted the logistics of
the refereeing process with high
efficiency. Our thanks also go to the
authors who submitted their papers
to this issue and to the referees whose
reviews and feedback helped to
improve the manuscripts.
Mounir Laroussi
Old Dominion University, USA
Guest Editor
Alexander Fridman
Drexel University, USA
Guest Editor
Editorial
Foreword
The Information Age has fundamen-
tally changed the approach to medi-
cine. Most technologies we are using
today in Medicine are Industrial
Age technologies, mainly mechanical
instruments, some electronic instru-
ments and monitors, and numerous
chemical-based drugs and materials.
The Information Age is totally differ-
ent, and was captured best by Nicho-
las Negroponte in his book ‘‘Being
Digital’’[1] where he states that the
defining characteristic of the Informa-
tion Age is replacing physical objects
with non-physical entities - ‘‘it’s bits
and bytes instead of atoms’’. For
Medicine the expression of this would
be to say ‘‘It is no longer blood and
guts, but bits and bytes’’.
We have just begun the transition
into the Information Age by moving
to an electronic medical record, net-
working with telemedicine (rather
than having people everywhere),
and using electrocoagulation or lasers
instead of scissors and scalpels. In
short, replacing supplies and instru-
ments with information and energy.
This concept has an enormous advan-
tage, because today’s large diagnostic
and therapeutic systems that are
currently separate tools, used at
different places and scheduled for
different times can nowminiaturized,
integrated and used in real time at the
patient bedside. One current example
of this application of energy would be
ultrasound. Diagnostic ultrasound
can be coupled with high-intensity-
focused-ultrasound (HIFU) into a
small, hand-held instrument. Using
the Doppler, internal hemorrhage can
be diagnosed, and activating the HIFU
can coagulate the tissues and stop the
bleeding - all from outside the body in
real time at the patient bedside.
Another analogy for information
and energy sharing is that networking
of the information makes the entire
patient care episode and the medical
system an integrated entity. For
example, when a labeled supply, such
as a sponge or disposable scissors is
used, the system automatically bills
the patient, orders new supplies for
the floor or room and sends a request
to the central supply to order a
replacement from the vendor - all
immediately and efficiently.
Likewisewith plasmamedicine, the
promise is to replace numerous phy-
sical objects with energy. Instead of
using alcohol, iodine or merthiolate to
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sterilize supplies, the application of
plasma energy can achieve the same
results (sterilization) without physical
supplies. No more need for ordering,
waiting for delivery, maintaining
inventory, distribution throughout
the hospital, storage until use, and
re-ordering when utilized. In a hand-
held plasma instrument, it may be
possible to attain the same sterility
without the huge logistical chain and
cost. Plasma sterilization would be
available whenever needed, at the
point of care and in real time, without
the need to reorder more supplies.
This dramatically improves the deliv-
ery, efficiency, cost effectiveness, and
safety of patient care.
On a more speculative note, it
might also be possible to continuously
sterilize supplies, instruments and
equipment while they are being used.
If a plasma could be distributed over
the surface of an instrument continu-
ously while operating, there would be
no need to sterilize instruments or run
quality checks in the factory but
rather they could be shipped non-
sterile at incredible cost savings. Every
day there is a significant loss of supply
usage because the supply or disposa-
ble instrument gets out of date or
contaminated before or during a
procedure, requiring opening of a
new sterile replacement, thereby
increasing the cost for the procedure.
Finally, it may be possible to monitor
the instrument by measuring the
change in the plasma characteristics.
This Special Issue represents one of
the first attempts to describe and
understand the potential use of
plasma applied to medicine. The
preliminary success in treating cuta-
neous leishmaniasis, which is not
treatable with topical medicines and
requires surgical excision, demon-
strates the potential of plasma med-
icine. Certainly, many other applica-
tions beyond those speculated above
will be discovered, while some of
them will be proven to be ineffective
- that is the hard science. However, the
basic hypothesis is sound: replace-
ment of physical objects with energy
can significantly improve the quality,
efficiency, safety, and cost of health-
care. What now remains is the dis-
covery and validation of these poten-
tial opportunities for the application
of plasma in medicine.
Richard M. Satava
University of Washington
Seattle, WA
[1] N. Negroponte, ‘‘Being Digital’’, Vintage
Books, New York 1996.
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